Journal article
Machine Learning Detects Pan-cancer Ras Pathway Activation in The Cancer Genome Atlas
Cell reports (Cambridge), Vol.23(1), pp.172-180.e3
04/03/2018
DOI: 10.1016/j.celrep.2018.03.046
PMCID: PMC5918694
PMID: 29617658
Abstract
Precision oncology uses genomic evidence to match patients with treatment but often fails to identify all patients who may respond. The transcriptome of these "hidden responders" may reveal responsive molecular states. We describe and evaluate a machine-learning approach to classify aberrant pathway activity in tumors, which may aid in hidden responder identification. The algorithm integrates RNA-seq, copy number, and mutations from 33 different cancer types across The Cancer Genome Atlas (TCGA) PanCanAtlas project to predict aberrant molecular states in tumors. Applied to the Ras pathway, the method detects Ras activation across cancer types and identifies phenocopying variants. The model, trained on human tumors, can predict response to MEK inhibitors in wild-type Ras cell lines. We also present data that suggest that multiple hits in the Ras pathway confer increased Ras activity. The transcriptome is underused in precision oncology and, combined with machine learning, can aid in the identification of hidden responders.
Details
- Title: Subtitle
- Machine Learning Detects Pan-cancer Ras Pathway Activation in The Cancer Genome Atlas
- Creators
- Gregory P Way - University of PennsylvaniaFrancisco Sanchez-Vega - Memorial Sloan Kettering Cancer CenterKonnor La - Memorial Sloan Kettering Cancer CenterJoshua Armenia - Memorial Sloan Kettering Cancer CenterWalid K Chatila - Memorial Sloan Kettering Cancer CenterAugustin Luna - Harvard UniversityChris Sander - Harvard UniversityAndrew D Cherniack - Massachusetts Institute of TechnologyMarco Mina - University of LausanneGiovanni Ciriello - University of LausanneNikolaus Schultz - Memorial Sloan Kettering Cancer CenterYolanda Sanchez - Dartmouth CollegeCasey S Greene - University of Pennsylvania
- Contributors
- Cancer Genome Atlas Research Network (Contributor)Deqin Ma (Contributor) - University of Iowa, PathologyMohammed M Milhem (Contributor) - University of Iowa, Internal MedicineAaron D Bossler (Contributor) - University of Iowa, Pathology
- Resource Type
- Journal article
- Publication Details
- Cell reports (Cambridge), Vol.23(1), pp.172-180.e3
- DOI
- 10.1016/j.celrep.2018.03.046
- PMID
- 29617658
- PMCID
- PMC5918694
- NLM abbreviation
- Cell Rep
- ISSN
- 2211-1247
- eISSN
- 2211-1247
- Grant note
- U24 CA143843 / NCI NIH HHS U24 CA210957 / NCI NIH HHS U54 HG003079 / NHGRI NIH HHS P30 CA016672 / NCI NIH HHS U24 CA143883 / NCI NIH HHS U24 CA210990 / NCI NIH HHS U24 CA143799 / NCI NIH HHS T32 HG000046 / NHGRI NIH HHS R50 CA221675 / NCI NIH HHS U24 CA143867 / NCI NIH HHS U24 CA143858 / NCI NIH HHS U24 CA143882 / NCI NIH HHS P30 CA008748 / NCI NIH HHS U54 HG003067 / NHGRI NIH HHS U24 CA143845 / NCI NIH HHS R01 NS095411 / NINDS NIH HHS U24 CA143835 / NCI NIH HHS U54 HG003273 / NHGRI NIH HHS U24 CA143840 / NCI NIH HHS U24 CA144025 / NCI NIH HHS U24 CA143866 / NCI NIH HHS P30 ES013508 / NIEHS NIH HHS U24 CA210949 / NCI NIH HHS U24 CA143848 / NCI NIH HHS R01 CA163722 / NCI NIH HHS
- Language
- English
- Date published
- 04/03/2018
- Academic Unit
- Hematology, Oncology, and Blood & Marrow Transplantation; Pathology; Internal Medicine
- Record Identifier
- 9984183983902771
Metrics
17 Record Views